HIV-1 acquisition in a man with ulcerative colitis on anti-α4β7 mAb vedolizumab treatment

AIDS. 2020 Sep 1;34(11):1689-1692. doi: 10.1097/QAD.0000000000002619.

Authors

Jesper Damsgaard Gunst^{1

2}, Mariane Høgsbjerg Schleimann^{1

2}, Marie Høst Pahus^{1

2}, Lars Østergaard^{1

2}, Martin Tolstrup^{1

2}, Ole Schmeltz Søgaard^{1

2}

Affiliations

¹ Department of Infectious Diseases.
² Institute of Clinical Medicine, Aarhus University, Aarhus N, Denmark.

PMID: 32769767
DOI: 10.1097/QAD.0000000000002619

No abstract available

MeSH terms

Anti-HIV Agents / therapeutic use*
Antibodies, Monoclonal, Humanized / adverse effects
Antibodies, Monoclonal, Humanized / blood
Antibodies, Monoclonal, Humanized / therapeutic use*
Colitis, Ulcerative / drug therapy*
Gastrointestinal Agents / blood
Gastrointestinal Agents / therapeutic use*
HIV Infections / complications
HIV Infections / diagnosis*
HIV Infections / drug therapy
HIV-1
Humans
Integrins / blood*
Male

Substances

Anti-HIV Agents
Antibodies, Monoclonal, Humanized
Gastrointestinal Agents
Integrins
vedolizumab